INGN Inogen Inc.

Inogen Recognized as a Finalist for Ragan's CSR & Diversity Awards Program

(Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that it has been selected as a finalist in the Diversity, Equity & Inclusion Commitment Category for Ragan's . This recognition celebrates the outstanding efforts of organizations that have demonstrated exemplary commitment to corporate social responsibility and fostering diversity and inclusion within their communities and workplaces.

The winners of Ragan's CSR & Diversity Awards will be announced during a on September 28, 2023, held at the Yale Club in New York City. The event will bring together leading industry professionals, CSR advocates and DE&I champions to celebrate the finalists and their exceptional contributions.

Ragan's CSR & Diversity Awards program honors companies and individuals who have displayed exceptional dedication to making a positive impact on society and promoting diversity in all its forms. Being recognized as a finalist is a testament to Inogen's commitment to driving positive change.

Inogen was chosen from a wide pool of entries to receive recognition as a FINALIST in Ragan’s CSR & Diversity Awards in the Diversity, Equity & Inclusion Commitment category for its FreshAir@Inogen campaign led by their internal Diversity, Equity, Inclusion, Belonging & Accessibility (DEIBA) Taskforce which began in June of 2022.

Highlights of the program include a 50-person volunteer DEIBA Taskforce that established a DEIBA Vision and principles to guide their work as they tackled modernizing benefit plans, improving selection processes, ensuring equitable compensation, a monthly roadmap of internal communications and stories by associates about their experiences and achievements, engagement surveys, mentoring, and both psychological safety and inclusive leader training.

Executive Vice President and Chief Human Resources Officer Jen Yi Boyer shared, “The ways that our associates have embraced this work provide endless proof points celebrating the strength of our culture and desire of our team members to make a difference every single day. Our focus on initiating collaborative dialogue through shared storytelling at all levels of the organization from the board of directors to our front-line teams created a sense of community and belonging leading to measurable improvements in engagement.”

For more information about the Ragan's CSR & Diversity Awards Program 2023 and the upcoming awards luncheon, you can .

About Inogen

Inogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available allowing patients the chance to remain ambulatory while managing the impact of their disease.

For more information, please visit .

Inogen has used, and intends to continue to use, its Investor Relations website, , as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit .

About Ragan Communications and PR Daily:

Ragan Communications has been delivering trusted news, training, and intelligence for more than 50 years to internal and external communicators and business executives via its conferences, webinars, training, awards, subscriptions and its membership divisions. Its daily news sites—PRDaily.com and Ragan.com — are read by more than 600,000 internal and external communicators monthly.

EN
08/08/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Inogen Inc.

 PRESS RELEASE

Inogen Announces First Quarter 2024 Financial Results

GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended March 31, 2024. “We are pleased to be off to a solid start at Inogen in 2024. Looking forward, we remain focused on positioning the business for revenue growth, improving our operating discipline to drive long-term profitability, and investing in our innovation pipeline to broaden our product portfolio,” said Kevin Smith, President and Chief Executive Officer. “The performance in the quart...

 PRESS RELEASE

Inogen to Report First Quarter 2024 Financial Results on May 7, 2024

GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2024 financial results after the market closes on Tuesday, May 7, 2024. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET. Individuals interested in listening to the conference call may do so by dialing: US domestic callers (877) 841-3961 Non-US callers (201) 689-8589 Please reference Inogen to join the call. A live audio webcast and archived recording o...

 PRESS RELEASE

Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference

GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced management will participate in the 23rd Annual Needham Virtual Healthcare Conference. Kevin Smith, President and Chief Executive Officer, and Michael Bourque, Chief Financial Officer, are scheduled to participate in a fireside chat on Tuesday, April 9, 2024, at 9:30 a.m. Eastern Time. A live audio webcast and archived recording of the presentation will be available to all interested parties through the page on the Inogen web...

 PRESS RELEASE

Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(...

GOLETA, Calif.--(BUSINESS WIRE)-- . (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that, effective March 4, 2024, the Compensation Committee of Inogen’s Board of Directors approved awards of restricted stock units as material inducement to Michael Bourque entering into employment with the company to serve as its Executive Vice President, Chief Financial Officer and Treasurer. The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity aw...

 PRESS RELEASE

Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results

GOLETA, Calif.--(BUSINESS WIRE)-- . (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the full-year ended December 31, 2023. “I am excited for the future of Inogen. As we progress into 2024, we are focused on positioning the business for revenue growth and long-term profitability while advancing our innovation pipeline and working to bring Physio-Assist to the U.S. market,” said Kevin Smith, President and Chief Executive Officer. “We have a strong management team with...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch